The most common in vivo application of clone MPC11 in mice is as a mouse IgG2b isotype control antibody. It is specifically used to distinguish nonspecific background effects from those caused by a test antibody of the same isotype during in vivo experiments.

Key uses in vivo include:

• Negative control: MPC11 does not bind specifically to any known mouse antigen. It acts as a nonreactive, isotypematched negative control, enabling researchers to identify nonspecific binding and background immune responses that are independent of the experimental antibody's specificity.
• Immunological assays: Frequently used alongside test antibodies in diverse settings such as immunooncology, infectious disease, and inflammation studies to ensure valid interpretation of results by ruling out artifacts from general IgG2b interactions.
• Functional and safety studies: MPC11 helps confirm that any observed biological effects are due to the specific binding of a targeting antibody, rather than to generic antibody effects or Fcreceptor interactions.
• Typical in vivo applications: These include evaluation of immune cell depletion, tumor growth studies, and pharmacokinetic or toxicological evaluation of novel antibody therapeutics.

Summary Table: Most Common In Vivo Applications for MPC11 in Mice

Additional context:

• MPC11 is formulated for in vivo administration with low endotoxin levels and has been validated to show minimal crossreactivity and no target specificity in mouse tissues.
• It is an essential reagent for regulatory and publication standards, ensuring the specificity and reliability of antibodybased therapeutics and mechanistic studies in mouse models.

MPC11 is not used to target or neutralize antigens in vivo; its primary value is as a nonbinding, isotype control to support rigorous, interpretable experiments in immunology and related fields.

While there isn't a comprehensive list of specific antibodies or proteins commonly used with MPC11 in the provided search results, MPC11 itself is often used as an isotype control for other antibodies, particularly in studies involving mouse models. It is used to ensure that any observed effects are due to the specific antibody being tested rather than the isotype itself. Here are some contexts and applications where MPC11 might be used alongside other antibodies:

1. In Vivo Applications: MPC11 is often used in conjunction with therapeutic or experimental antibodies to provide a control for specificity in mouse models. This includes studies on immune checkpoint controls (e.g., antiPD1/PDL1/CTLA4), immune cell depletion controls, and chronic treatment regimens.

2. Apoptosis Pathways: Although not directly mentioned with MPC11, antibodies like Caspase3, Caspase8, and Caspase9 are commonly used in apoptosis studies, which might involve using MPC11 as a control if the experimental antibodies are IgG2b isotype.

3. Flow Cytometry: MPC11 is used in flow cytometry setups, often in combination with various dyes or other markers to analyze cell populations. This could involve using it alongside other antibodies for multicolor flow cytometry.

4. General Research: In broader research contexts, MPC11 would be used as a control in various experiments involving mouse IgG2b antibodies. The specific antibodies used alongside MPC11 would depend on the experimental design and the biological question being addressed.

If you're looking for specific antibodies or proteins used with MPC11 in a particular study or context, it would be helpful to consult the relevant research articles directly.

Key findings from clone MPC11 citations in scientific literature demonstrate its central role as both a research cell line in immunology and as a widely adopted isotype control antibody in experimental design:

• Origins and Biology:

  • MPC11 is a mouse myeloma cell line originally established for studying the structure and synthesis of immunoglobulins, particularly IgG2b subtype antibodies.
  • MPC11 cells produce fully assembled gamma globulin molecules (IgG2b), as well as immunoglobulin halfmolecules, lightchain dimers, and free light chains, resembling the original tumor in these features.

• Immunoglobulin Class Switching:

  • The MPC11 cell line was key in early discoveries of immunoglobulin heavy chain class switching. Spontaneous variants of MPC11 can switch from IgG2b to IgG2a production at high frequency, making this line a powerful model for studying DNA rearrangements associated with antibody class switching.
  • All switch variants express the original heavy chain variable region (VH) gene, so the class switch occurs in the constant region of the immunoglobulin gene rather than the variable region.
  • This system has been critical for understanding the mechanisms and mapping the genetic events underlying classswitch recombination in B cells.

• Functional Role in Experimental Design:

  • Monoclonal antibodies prepared from MPC11 are nonreactive isotypematched controls for mouse IgG2b, used to distinguish specific antibody effects from nonspecific Fcmediated effects or background binding.
    • MPC11 isotype controls are widely used in:
      • In vivo immunology studies: For example, as controls for immune checkpoint inhibitors (e.g., antiPD1/PDL1)
      • Cell depletion assays: To ensure observed effects are due to the activity of the test antibody
      • Flow cytometry and in vitro assays: To measure and account for nonspecific binding by IgG2b antibodies
    • The control is characterized by minimal crossreactivity and stable biochemical properties.
    • The dosing and application of MPC11 isotype controls are matched with test antibodies to ensure appropriate experimental comparison (standard dose: 100–250 µg/mouse i.p., with precise amounts and routes adjusted to match the experimental antibody).
    • It is specifically chosen for its lack of functional activity in target engagement, making it ideal as a negative control.

• Hybrid Resistance and Tumor Models:

  • MPC11 has also been used in genetic studies on mouse tumor resistance, revealing distinct resistance mechanisms compared to other myeloma cells like P815, controlled by unique genetic loci.

Summary of Impact:

• MPC11 is foundational in antibody research: as a model for class switch recombination, as a producer of IgG2b, and most prominently, as the standard isotype control for mouse IgG2b antibodies in immunology, oncology, and cell biology experiments.

If you need findings related to a specific disease model, antibody application, or experimental context using MPC11, please specify further.

Dosing Regimens of Clone MPC11 Across Mouse Models

Clone MPC11 refers to a mouse IgG2b isotype control monoclonal antibody commonly used in immunological research, particularly as a negative control to assess nonspecific binding in both in vitro and in vivo assays. Its primary function is not to target or neutralize any specific antigen but to serve as a matched control for experimental antibodies of the same isotype.

General Dosing Principles

• Dosing regimens for MPC11 are not standardized across different mouse models; instead, they are specifically matched to the experimental antibody under investigation.
• Investigators are advised to match the dose, route of administration, and schedule of MPC11 to those of the primary antibody used in their study, adjusting only if experimental needs require.
• The working concentration of MPC11 should generally be the same as that of the primary antibody, ensuring that any observed effects are due to the specificity of the experimental antibody and not nonspecific interactions.
• No typical or universal dosing schedule for MPC11 is published; the regimen is entirely contextdependent, reflecting the design of the primary experiment.

Variability Across Models

• Published regimens for MPC11 vary by context: The dose, frequency, and method of administration are most commonly chosen to mirror the test antibody regimen in each specific model and experiment.
• There is no evidence in the literature of MPC11 dosing being adjusted based on strain, age, or disease model. Instead, the emphasis is on consistency with the primary antibody's regimen to maintain experimental validity.
• Product datasheets and manufacturer guidance do not specify different dosing for different mouse models. They recommend referencing direction on lotspecific datasheets and adjusting only as needed for the experiment.

Practical Recommendations

• Consult the datasheet for the specific lot of MPC11 being used, as recommendations may be updated based on manufacturing batches.
• Determine the optimal working dilution for your application, as optimal concentrations can vary depending on assay type (e.g., flow cytometry, immunohistochemistry, in vivo studies).
• If in doubt, contact the manufacturer or reference recent literature using MPC11 in similar experimental setups for guidance on dosing.

Summary Table

Conclusion

The dosing regimen for clone MPC11 does not intrinsically vary across different mouse models. Instead, it is tailored to match the specific experimental antibody in use, ensuring that observed effects are attributable to the primary antibody's specificity and not to nonspecific interactions. Always align MPC11 dosing with your experimental antibody’s regimen and consult productspecific guidance for optimal results.